Skip to main content
. 2019 Oct 9;10:2268. doi: 10.3389/fmicb.2019.02268

FIGURE 3.

FIGURE 3

Receiver operating characteristic curve for cutoff of rK39 AB titer for prediction of asymptomatic at risk for VL within subsequent 24 months.